Emanuela Mazzon Selected Research

Emanuela Mazzon Research Topics

Disease

147	Inflammation (Inflammations) 06/2023 - 01/2002
56	Spinal Cord Injuries (Spinal Cord Injury) 12/2022 - 02/2005
32	Ischemia 12/2014 - 08/2002
31	Edema (Dropsy) 01/2019 - 05/2002
31	Necrosis 01/2016 - 01/2002
31	Shock 06/2012 - 03/2002
29	Myelitis 04/2012 - 02/2005
28	Lung Injury 03/2024 - 01/2002
28	Reperfusion Injury 01/2024 - 01/2002
28	Colitis 08/2011 - 05/2002
26	Multiple Sclerosis 02/2024 - 08/2013
26	Pleurisy (Pleuritis) 01/2024 - 01/2002
26	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 11/2014
25	Body Weight (Weight, Body) 05/2012 - 10/2002
22	Wounds and Injuries (Trauma) 09/2023 - 07/2002
19	Pancreatitis 03/2024 - 05/2002
19	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2011 - 05/2002
18	Neoplasms (Cancer) 10/2021 - 06/2004
16	Multiple Organ Failure (MODS) 02/2024 - 10/2002
15	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 12/2016
15	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 08/2013
15	Pneumonia (Pneumonitis) 10/2011 - 03/2004
14	Arthritis (Polyarthritis) 01/2024 - 10/2002
13	Parkinson Disease (Parkinson's Disease) 11/2023 - 01/2012
12	Neuroinflammatory Diseases 04/2023 - 01/2011
10	Periodontitis 08/2017 - 06/2005
10	Diarrhea 10/2015 - 05/2002
10	Experimental Arthritis 12/2011 - 01/2002
10	Septic Shock (Toxic Shock Syndrome) 07/2011 - 11/2002
9	Neuroblastoma 04/2023 - 07/2017
9	Hypoxia (Hypoxemia) 05/2020 - 12/2004
9	Hemorrhage 05/2012 - 05/2002
9	Weight Loss (Weight Reduction) 02/2009 - 07/2002
7	Disease Progression 11/2023 - 12/2016
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

53	3-nitrotyrosineIBA 10/2015 - 05/2002
50	CytokinesIBA 10/2021 - 06/2002
41	Peroxidase (Myeloperoxidase)IBA 11/2011 - 02/2003
39	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 02/2003
34	CarrageenanIBA 01/2024 - 01/2002
25	NF-kappa B (NF-kB)IBA 12/2014 - 01/2002
24	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2006
24	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2014 - 01/2002
23	EnzymesIBA 07/2020 - 01/2002
23	DinitrobenzenesIBA 08/2011 - 07/2002
22	LigandsIBA 01/2024 - 12/2003
22	ZymosanIBA 09/2011 - 01/2002
21	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2024 - 01/2002
20	2,4-dinitrofluorobenzene sulfonic acidIBA 08/2011 - 07/2002
19	Sulfonic AcidsIBA 08/2011 - 05/2002
18	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 12/2004
18	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2014 - 01/2002
17	CeruletideIBA 03/2024 - 05/2002
16	PPAR alphaIBA 01/2010 - 10/2004
15	AntioxidantsIBA 12/2022 - 07/2003
15	GlucocorticoidsIBA 02/2017 - 11/2004
14	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023 - 07/2002
14	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2002
14	Interleukin-1beta (Interleukin 1 beta)IBA 04/2009 - 01/2002
13	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2019 - 01/2002
13	Lipase (Acid Lipase)FDA Link 07/2012 - 05/2002
13	Amylases FDA Link 07/2012 - 05/2002
13	Peroxynitrous Acid (Peroxynitrite)IBA 11/2010 - 11/2002
13	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2010 - 02/2005
12	moringinIBA 05/2021 - 01/2016
12	Neuroprotective AgentsIBA 01/2018 - 02/2011
11	CannabinoidsIBA 01/2024 - 11/2014
11	Collagen Type II (Type II Collagen)IBA 01/2024 - 10/2002
11	Poly Adenosine Diphosphate RiboseIBA 07/2011 - 08/2002
11	Bleomycin (Blenoxane)FDA LinkGeneric 07/2011 - 05/2005
10	MicroRNAs (MicroRNA)IBA 02/2024 - 08/2019
10	isothiocyanic acidIBA 03/2023 - 01/2015
10	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2002
10	thioglucosidaseIBA 04/2019 - 08/2013
10	P-SelectinIBA 10/2015 - 01/2002
9	MelatoninIBA 05/2020 - 04/2005
9	Interleukin-6 (Interleukin 6)IBA 01/2011 - 06/2002
8	Macrophage Migration-Inhibitory FactorsIBA 03/2020 - 01/2018
8	InterleukinsIBA 12/2019 - 08/2002
8	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015 - 06/2005
8	AcidsIBA 04/2011 - 07/2002
8	ProstaglandinsIBA 07/2009 - 05/2002
7	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2005
7	Glycogen Synthase (Synthase I)IBA 01/2024 - 05/2006
7	LipopolysaccharidesIBA 03/2022 - 03/2003
7	GlucosinolatesIBA 01/2022 - 01/2016
7	CannabidiolIBA 06/2020 - 10/2015
7	PolyphenolsIBA 04/2016 - 05/2005
7	Fas Ligand Protein (Fas Ligand)IBA 11/2011 - 11/2006
7	Nitric Oxide Synthase (NO Synthase)IBA 11/2011 - 05/2002
7	Tyrosine (L-Tyrosine)FDA Link 05/2011 - 11/2005
7	Superoxides (Superoxide)IBA 11/2010 - 07/2002
7	Uridine Triphosphate (UTP)IBA 02/2010 - 02/2005
7	salicylhydroxamic acid (SHAM)IBA 01/2010 - 01/2004
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2007 - 01/2002
6	Monoclonal AntibodiesIBA 01/2024 - 10/2004

Therapy/Procedure

42	Therapeutics 01/2023 - 01/2002
34	Laminectomy 01/2015 - 02/2005
15	Intraperitoneal Injections 07/2012 - 05/2002
7	Ligation 05/2011 - 10/2005